WallStreetZenWallStreetZen

NASDAQ: ADMA
Adma Biologics Inc Earnings & Revenue

ADMA past revenue growth

How has ADMA's revenue growth performed historically?
Company
55.68%
Industry
82.48%
Market
19.08%
ADMA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADMA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ADMA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ADMA earnings and revenue history

Current Revenue
$283.2M
Current Earnings
-$3.6M
Current Profit Margin
-1.3%

ADMA Return on Equity

Current Company
-2.5%
Current Industry
16.8%
Current Market
28.2%
ADMA's Return on Equity (-2.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ADMA announces earnings.

ADMA Return on Assets

Current Company
-1.1%
Current Industry
3.2%
ADMA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ADMA Return on Capital Employed

Current Company
6.59%
Current Industry
-42.4%
ADMA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADMA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ADMA$283.18M$28.04M-$3.64M+76.63%N/A
AGIO$29.40M-$335.52M-$352.62M-23.99%N/A
RYTM$91.93M-$255.54M-$273.87M+1,379.54%N/A
ACAD$813.81M$25.56M-$1.71M+27.89%N/A
MLTX$0.00-$45.65M-$45.84MN/AN/A

ADMA earnings dates

Next earnings date
Aug 7, 2024

Adma Biologics Earnings & Revenue FAQ

What were ADMA's earnings last quarter?

On Invalid Date, Adma Biologics (NASDAQ: ADMA) reported Q1 2024 earnings per share (EPS) of $0.08, up 366.67% year over year. Total Adma Biologics earnings for the quarter were $17.81 million. In the same quarter last year, Adma Biologics's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Adma Biologics stock.

What was ADMA's earnings growth in the past year?

As of Q2 2024, Adma Biologics's earnings has grown year over year. Adma Biologics's earnings in the past year totalled -$3.64 million.

What is ADMA's earnings date?

Adma Biologics's earnings date is Invalid Date. Add ADMA to your watchlist to be reminded of ADMA's next earnings announcement.

What was ADMA's revenue last quarter?

On Invalid Date, Adma Biologics (NASDAQ: ADMA) reported Q1 2024 revenue of $81.88 million up 43.86% year over year. In the same quarter last year, Adma Biologics's revenue was $56.91 million.

What was ADMA's revenue growth in the past year?

As of Q2 2024, Adma Biologics's revenue has grown 55.68% year over year. This is 26.79 percentage points lower than the US Biotechnology industry revenue growth rate of 82.48%. Adma Biologics's revenue in the past year totalled $283.18 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.